Speaker illustration

Doctor Takuro Abe

Nishiarai Heart Center, Tokyo (Japan)

Heart failure re-hospitalization differently affects the following mortality in patients with reduced, mid-range and preserved LVEF

Event: ESC Congress 2021 - The Digital Experience

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure e-posters


Insufficient lipid lowering therapy could not bring favorable prognostic effect in high risk patients who were functionally deferred percutaneous coronary intervention

Event: ESC Congress 2020

Topic: Angiography, Invasive Imaging

Session: Coronary Artery Disease (Chronic) ePosters


The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

Event: ESC Congress 2018

Topic: Aldosterone Antagonists

Session: Cardiovascular drug therapy in special populations


Guideline-recommended medication including mineralocorticoid-receptor antagonists is associated with better long-term outcomes in octogenarian patients with acute heart failure.

Event: ESC Congress 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Strategies to optimize established heart failure therapies


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb